Third Avenue Management Catalyst Pharmaceuticals Inc

1 Third Avenue Management Catalyst Pharmaceuticals Trades

Third Avenue Management's position in Catalyst Pharmaceuticals is currently worth $6.57M. That's 1.03% of their equity portfolio (31st largest holding). The stake costed the investor $5.01M, netting the investor a gain of 31% so far.

News about Catalyst Pharmaceuticals Inc and Third Avenue Management

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Position Raised by Geode Capital Management LLC

Geode Capital Management LLC raised its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) by 5.5% during the second quarter, according to its most recent...

Dakota Financial News, over 4 years ago